<p>Brown Advisory Inc. 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第二季度减少了对 LifeStance Health Group, Inc. (NASDAQ:LFST - 免费报告) 的持股比例，减少幅度为 10.5%。该机构投资者在此期间出售了 611,977 股后，持有该公司 5,210,638 股股票。Brown Advisory Inc. 在最近的报告期末持有 LifeStance Health Group 约 1.34% 的股份，价值 26,939,000 美元。</p>
<p>其他一些机构投资者也最近对该股票的持仓进行了调整。Jacobs Levy Equity Management Inc. 在第一季度以 7,932,000 美元的估值购买了 LifeStance Health Group 的新头寸。Adage Capital Partners GP L.L.C. 在第一季度将其在 LifeStance Health Group 的股份增加了 43.8%。Adage Capital Partners GP L.L.C. 目前持有该公司 230,000 股股票，价值 1,532,000 美元，此前在上个季度又购买了 70,000 股。TD Asset Management Inc 在第二季度以约 780,000 美元的估值购买了 LifeStance Health Group 的新头寸。Nuveen LLC 在第一季度以约 6,928,000 美元的估值购买了 LifeStance Health Group 的新股份。最后，洛杉矶资本管理公司在第二季度以约 219,000 美元的估值购买了 LifeStance Health Group 的新股份。机构投资者持有该公司 85.50% 的股份。</p>
<h2>分析师评级调整</h2>
<p>多位研究分析师对 LFST 股票发表了评论。Zacks Research 在 11 月 5 日的研究报告中将 LifeStance Health Group 的股票评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。BMO Capital Markets 于 11 月 13 日的研究报告中开始覆盖 LifeStance Health Group 的股票，给予 &#34;跑赢大盘&#34; 的评级和 8.00 美元的目标价。BTIG Research 在 11 月 6 日的研究报告中将 LifeStance Health Group 的目标价从 8.00 美元上调至 9.00 美元，并给予该股票 &#34;买入&#34; 的评级。华尔街禅在 10 月 11 日的研究报告中将 LifeStance Health Group 的评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。最后，瑞银集团在 11 月 7 日的研究报告中将 LifeStance Health Group 的目标价从 9.00 美元上调至 10.00 美元，并给予该公司 &#34;买入&#34; 的评级。一位股票研究分析师给予该股票 &#34;强力买入&#34; 的评级，六位分析师给予 &#34;买入&#34; 的评级，一位分析师给予 &#34;持有&#34; 的评级，一位分析师给予 &#34;卖出&#34; 的评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，平均目标价为 9.00 美元。</p>
<p><strong>查看我们对 LFST 的最新股票分析</strong></p>
<h2>LifeStance Health Group 的内部买卖</h2>
<p>在其他消息中，内部人士 Lisa K. Miller 于 11 月 21 日星期五出售了 57,240 股该公司的股票。该股票以平均价格 6.43 美元出售，总交易额为 368,053.20 美元。交易后，内部人士直接持有该公司 261,292 股股票，价值约 1,680,107.56 美元。此次交易使其持股比例减少了 17.97%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。公司内部人士持有该公司 3.20% 的股份。</p>
<h2>LifeStance Health Group 的价格表现</h2>
<p>LFST 股票在星期五开盘价为 6.48 美元。该股票的市值为 25.2 亿美元，市盈率为 -216.00，贝塔值为 1.13。该公司的 50 日移动平均价格为 5.72 美元，200 日移动平均价格为 5.30 美元。公司当前比率为 1.58，速动比率为 1.58，债务与股本比率为 0.18。LifeStance Health Group, Inc. 的 12 个月低点为 3.74 美元，12 个月高点为 8.30 美元。</p>
<p>LifeStance Health Group (NASDAQ:LFST - 获取免费报告) 最近于 11 月 5 日发布了其财报。该公司报告本季度每股收益为 0.02 美元，超出分析师一致预期的 -0.01 美元，超出幅度为 0.03 美元。LifeStance Health Group 的净利润率为 -0.67%，股本回报率为 -0.62%。该公司本季度的收入为 3.6381 亿美元，而分析师预期为 3.5506 亿美元。在去年同期，该公司每股收益为 -0.02 美元。LifeStance Health Group 本季度的收入同比增长 16.3%。整体来看，股票分析师预测 LifeStance Health Group, Inc. 本年度每股收益将为 -0.18 美元。</p>
<h2>关于 LifeStance Health Group</h2>
<p>(免费报告)</p>
<p>LifeStance Health Group, Inc. 通过其子公司在美国提供儿童、青少年、成人和老年人的门诊心理健康服务。该公司为患者提供一系列心理健康服务，包括精神评估和治疗、心理测试和神经心理测试，以及个人、家庭和团体治疗。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 LifeStance Health Group</li>
<li>标普 500 股票对投资者的市场指示是什么？</li>
<li>Ulta 的股票可能会迎来反弹——20% 的上涨空间？</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>比尔和梅琳达·盖茨基金会出售 MSFT 股票——投资者应该担心吗？</li>
<li>什么是财报？</li>
<li>MarketBeat 周报 – 12/1 - 12/5</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 LifeStance Health Group 吗？</h2>
<p>在你考虑投资 LifeStance Health Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 LifeStance Health Group 并不在名单上。</p>
<p>虽然 LifeStance Health Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

LFST

<p>Brown Advisory Inc. 在第二季度减少了对 LifeStance Health Group 的持股比例，减持了 10.5%，共售出 611,977 股。分析师对 LFST 的评级不一，整体共识为适度买入，目标价为 9.00 美元。内部人士 Lisa K. Miller 售出了 57,240 股。LFST 报告第三季度每股收益为 0.02 美元，超出预期，营收同比增长 16.3%</p>

<p>Brown Advisory Inc. lessened its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 10.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,210,638 shares of the company's stock after selling 611,977 shares during the period. Brown Advisory Inc. owned approximately 1.34% of LifeStance Health Group worth $26,939,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Brown Advisory Inc. 在最近向证券交易委员会（SEC）提交的 13F 文件中表示，在第二季度减少了对 LifeStance Health Group, Inc. (NASDAQ:LFST - 免费报告) 的持股比例，减少幅度为 10.5%。该机构投资者在此期间出售了 611,977 股后，持有该公司 5,210,638 股股票。Brown Advisory Inc. 在最近的报告期末持有 LifeStance Health Group 约 1.34% 的股份，价值 26,939,000 美元。</p>
</div><p>A number of other institutional investors have also recently made changes to their positions in the stock. Jacobs Levy Equity Management Inc. bought a new position in LifeStance Health Group in the first quarter valued at $7,932,000. Adage Capital Partners GP L.L.C. increased its position in shares of LifeStance Health Group by 43.8% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company's stock valued at $1,532,000 after purchasing an additional 70,000 shares during the last quarter. TD Asset Management Inc purchased a new position in shares of LifeStance Health Group during the 2nd quarter valued at about $780,000. Nuveen LLC bought a new stake in LifeStance Health Group in the 1st quarter worth approximately $6,928,000. Finally, Los Angeles Capital Management LLC purchased a new stake in LifeStance Health Group in the second quarter worth approximately $219,000. Institutional investors own 85.50% of the company's stock.</p>
<div class="lb-trans"><p>其他一些机构投资者也最近对该股票的持仓进行了调整。Jacobs Levy Equity Management Inc. 在第一季度以 7,932,000 美元的估值购买了 LifeStance Health Group 的新头寸。Adage Capital Partners GP L.L.C. 在第一季度将其在 LifeStance Health Group 的股份增加了 43.8%。Adage Capital Partners GP L.L.C. 目前持有该公司 230,000 股股票，价值 1,532,000 美元，此前在上个季度又购买了 70,000 股。TD Asset Management Inc 在第二季度以约 780,000 美元的估值购买了 LifeStance Health Group 的新头寸。Nuveen LLC 在第一季度以约 6,928,000 美元的估值购买了 LifeStance Health Group 的新股份。最后，洛杉矶资本管理公司在第二季度以约 219,000 美元的估值购买了 LifeStance Health Group 的新股份。机构投资者持有该公司 85.50% 的股份。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>A number of research analysts have commented on LFST shares. Zacks Research cut shares of LifeStance Health Group from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Wednesday, November 5th. BMO Capital Markets began coverage on shares of LifeStance Health Group in a research report on Thursday, November 13th. They issued an &#34;outperform&#34; rating and a $8.00 target price on the stock. BTIG Research boosted their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, November 6th. Wall Street Zen cut LifeStance Health Group from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, October 11th. Finally, UBS Group boosted their target price on LifeStance Health Group from $9.00 to $10.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, November 7th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $9.00.</p>
<div class="lb-trans"><p>多位研究分析师对 LFST 股票发表了评论。Zacks Research 在 11 月 5 日的研究报告中将 LifeStance Health Group 的股票评级从 &#34;强力买入&#34; 下调至 &#34;持有&#34;。BMO Capital Markets 于 11 月 13 日的研究报告中开始覆盖 LifeStance Health Group 的股票，给予 &#34;跑赢大盘&#34; 的评级和 8.00 美元的目标价。BTIG Research 在 11 月 6 日的研究报告中将 LifeStance Health Group 的目标价从 8.00 美元上调至 9.00 美元，并给予该股票 &#34;买入&#34; 的评级。华尔街禅在 10 月 11 日的研究报告中将 LifeStance Health Group 的评级从 &#34;买入&#34; 下调至 &#34;持有&#34;。最后，瑞银集团在 11 月 7 日的研究报告中将 LifeStance Health Group 的目标价从 9.00 美元上调至 10.00 美元，并给予该公司 &#34;买入&#34; 的评级。一位股票研究分析师给予该股票 &#34;强力买入&#34; 的评级，六位分析师给予 &#34;买入&#34; 的评级，一位分析师给予 &#34;持有&#34; 的评级，一位分析师给予 &#34;卖出&#34; 的评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 &#34;适度买入&#34;，平均目标价为 9.00 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on LFST</strong></p>
<div class="lb-trans"><p><strong>查看我们对 LFST 的最新股票分析</strong></p>
</div><h2>Insider Buying and Selling at LifeStance Health Group</h2>
<div class="lb-trans"><h2>LifeStance Health Group 的内部买卖</h2>
</div><p>In other news, insider Lisa K. Miller sold 57,240 shares of the business's stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider directly owned 261,292 shares of the company's stock, valued at approximately $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 3.20% of the company's stock.</p>
<div class="lb-trans"><p>在其他消息中，内部人士 Lisa K. Miller 于 11 月 21 日星期五出售了 57,240 股该公司的股票。该股票以平均价格 6.43 美元出售，总交易额为 368,053.20 美元。交易后，内部人士直接持有该公司 261,292 股股票，价值约 1,680,107.56 美元。此次交易使其持股比例减少了 17.97%。该交易已在向证券交易委员会的备案中披露，相关信息可通过此链接访问。公司内部人士持有该公司 3.20% 的股份。</p>
</div><h2>LifeStance Health Group Price Performance</h2>
<div class="lb-trans"><h2>LifeStance Health Group 的价格表现</h2>
</div><p>LFST stock opened at $6.48 on Friday. The stock has a market capitalization of $2.52 billion, a price-to-earnings ratio of -216.00 and a beta of 1.13. The firm's 50-day moving average price is $5.72 and its two-hundred day moving average price is $5.30. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 0.18. LifeStance Health Group, Inc. has a 12-month low of $3.74 and a 12-month high of $8.30.</p>
<div class="lb-trans"><p>LFST 股票在星期五开盘价为 6.48 美元。该股票的市值为 25.2 亿美元，市盈率为 -216.00，贝塔值为 1.13。该公司的 50 日移动平均价格为 5.72 美元，200 日移动平均价格为 5.30 美元。公司当前比率为 1.58，速动比率为 1.58，债务与股本比率为 0.18。LifeStance Health Group, Inc. 的 12 个月低点为 3.74 美元，12 个月高点为 8.30 美元。</p>
</div><p>LifeStance Health Group (NASDAQ:LFST - Get Free Report) last posted its earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The company had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. During the same period in the prior year, the business posted ($0.02) earnings per share. LifeStance Health Group's revenue for the quarter was up 16.3% on a year-over-year basis. As a group, equities analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current year.</p>
<div class="lb-trans"><p>LifeStance Health Group (NASDAQ:LFST - 获取免费报告) 最近于 11 月 5 日发布了其财报。该公司报告本季度每股收益为 0.02 美元，超出分析师一致预期的 -0.01 美元，超出幅度为 0.03 美元。LifeStance Health Group 的净利润率为 -0.67%，股本回报率为 -0.62%。该公司本季度的收入为 3.6381 亿美元，而分析师预期为 3.5506 亿美元。在去年同期，该公司每股收益为 -0.02 美元。LifeStance Health Group 本季度的收入同比增长 16.3%。整体来看，股票分析师预测 LifeStance Health Group, Inc. 本年度每股收益将为 -0.18 美元。</p>
</div><h2>About LifeStance Health Group</h2>
<div class="lb-trans"><h2>关于 LifeStance Health Group</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.</p>
<div class="lb-trans"><p>LifeStance Health Group, Inc. 通过其子公司在美国提供儿童、青少年、成人和老年人的门诊心理健康服务。该公司为患者提供一系列心理健康服务，包括精神评估和治疗、心理测试和神经心理测试，以及个人、家庭和团体治疗。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than LifeStance Health Group</li>
<li>What Do S&amp;P 500 Stocks Tell Investors About the Market?</li>
<li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li>
<li>The 3 Best Blue-Chip Stocks to Buy Now</li>
<li>Gates Foundation Sells MSFT Stock—Should Investors Be Worried?</li>
<li>What Are Earnings Reports?</li>
<li>MarketBeat Week in Review – 12/1 - 12/5</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 LifeStance Health Group</li>
<li>标普 500 股票对投资者的市场指示是什么？</li>
<li>Ulta 的股票可能会迎来反弹——20% 的上涨空间？</li>
<li>现在购买的三只最佳蓝筹股</li>
<li>比尔和梅琳达·盖茨基金会出售 MSFT 股票——投资者应该担心吗？</li>
<li>什么是财报？</li>
<li>MarketBeat 周报 – 12/1 - 12/5</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TEZTVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=LFST"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in LifeStance Health Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 LifeStance Health Group 吗？</h2>
</div><p>Before you consider LifeStance Health Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑投资 LifeStance Health Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LifeStance Health Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 LifeStance Health Group 并不在名单上。</p>
</div><p>While LifeStance Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 LifeStance Health Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Brown Advisory Inc.出售了 611,977 股 LifeStance Health Group, Inc.的股票，股票代码为$LFST